Showing posts with label Daily Update - May 27. Show all posts
Showing posts with label Daily Update - May 27. Show all posts

Thursday, May 27, 2010

Global's H1N1 Update - 05/27/10

The next update will be on Tuesday, June 1st, at 0830 hrs PST.
The WHO Pandemic Alert level remains at Phase 6

Influenza A (H1N1) Cases and Deaths*

*Cases reported by The World Health Organization (WHO) are as of May 16, 2010



International News


Potential source for universal flu vaccine discovered

The American Society for Microbiology’s journal, mBio, has published a study outlining the construction of a headless version of the flu virus which may be used to create a universal flu vaccine. Currently, annual flu shots use epidemiological research and some guesswork to assemble a cocktail of three vaccines that target a narrow band of virus strains suspected of becoming that year’s dominant bug. Every so often a significant mutation occurs that allows the virus to sidestep existing vaccines and elude the body’s immune system, and a pandemic strain emerges.

The key lies in the hemagglutinin, which is what gives influenza virus strains the ‘H’ in their designations. Hemagglutinin is a protein structure on the virus that it uses to “glue” itself to the cells it infects. Because this attachment is an operation all viruses must be able to perform, portions of the protein are common to all strains, even mutated ones. Researchers at the Mount Sinai School of Medicine in New York isolated these conserved sequences on the protein to create a universal vaccine type. The experimental vaccine has already been used to protect mice from lethal doses of influenza virus.

Annual vaccines represent millions of dollars in income for the pharmaceutical industry. Last year Canada bought over 50 million doses of flu vaccine for its public vaccination program. The US bought over 162 million. Reuters

Doctor who was architect of vaccine-autism link banned from practicing medicine.

After finding him guilty of over 30 charges of professional misconduct and unethical behaviour, the United Kingdom’s General Medical Council has stricken Dr. Andrew Wakefield from the medical registry. In 1998, a research team led by Dr. Wakefield published a study in British medical journal The Lancet that concluded there was link between the administration of measles, mumps and rubella (MMR) vaccines and the onset of autism. The paper set off a 10-year storm of controversy as vaccine rates in England dropped, and measles case numbers rose. The Lancet retracted Wakefield’s study in February

No large scientific study has been able to reproduce these findings, but the General Medical Council (GMC) said their investigation was not concerned with whether or not the study’s findings were right or wrong, but the manner and the circumstances under which the study was conducted. Dr. Surendra Kumar, chair of the hearing committee said that the application of the council’s most severe sanction was the only measure “appropriate to protect patients and is in the wider public interest, including the maintenance of public trust and confidence in the profession, and is proportionate to the serious and wide-ranging findings made against him.”

Among the offences listed at the hearing were the way Dr. Wakefield gathered his blood samples, he paid children £5 each for them at his son’s birthday party; and his nondisclosure of the fact that had been paid £50,000 (about $72,000) by the lawyers of a parents’ group who were suing vaccine makers.

In a BBC interview, Wakefield said he never claimed to prove a link between MMR vaccines and autism, but at an appearance on NBC’s Today show, he claimed the autism link he established was the basis of a smear campaign against him of which the GMC’s ruling was a part. BBC News

Wednesday, May 27, 2009

Global's Daily Influenza A (H1N1) Update - May 27, 2009

GMS INFLUENZA A (H1N1) Daily Update as of May 27, 2009(830 HRS PST)

The WHO Pandemic Alert level remains at Phase 5.



Influenza A (H1N1) Cases and Deaths by Country (as of 8 AM PST, May 27th)
*Lab confirmed cases and deaths have been provided by the WHO’s Influenza A (H1N1) – Update #40.


Local/National News

  • On May 26th, the Public Health Agency of Canada (PHAC) did not revise the country’s confirmed influenza A (H1N1) case total. PHAC releases revised case totals on Mondays, Wednesdays, and Fridays.

International News

  • Health officials in Australia stated Tuesday that the number of confirmed novel H1N1 cases has risen to 44. That number is double what was reported by the WHO on Monday. Flu experts are watching Australia closely, because the novel flu outbreak comes as the country's seasonal influenza cycle is starting. Some of the newly confirmed patients were on a cruise ship that asked passengers to self-isolate after two boys on the ship tested positive for the virus. The Australian
  • Recently, Kathleen Sebelius, U.S. Health and Human Services secretary, launched a U.S. public service ad campaign aimed at teaching families and children how to protect themselves from the novel H1N1 virus. The campaign, featuring "Sesame Street" characters, received additional support from the Sesame Street educational workshop and the Ad Council. The spots were distributed nationwide and will be aired during time donated by television stations. HHS press release

  • The pace of novel H1N1 influenza is tapering off in most parts of the United States, except for around New York City and in New England, Anne Schuchat, MD, of the U.S. CDC said at a press briefing yesterday. Seasonal influenza strains have also receded, and the novel flu virus is the country's predominant circulating flu strain. CDC Press Transcript
  • The U.S. CDC is transitioning to a new focus of observing if the virus changes in the southern hemisphere, preparing for another possible wave of novel flu illness in the fall, and working to develop a vaccine. CDC Press Transcript

Today’s Key Question


What are the current recommendations regarding the use of facemasks and respirators for non-ill persons?


The U.S. CDC recently revised their Interim Recommendations for Facemask and Respirator Use for Home, Community, and Occupational Settings for Non-Ill Persons to Prevent Infection with Novel H1N1 1 2. The following table breaks down the recommendations into clear groupings.